Hideo

I, Hideo Mori, residing in Japan, a consulting expert of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am a director of Tokushima Renewable Energy, Incorporated General Association. My responsibility includes introduction and development of renewable energy generation systems in the region. I have been a private consultant for pharmaceutical industry.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests , and those of my personal partner and dependents, include the following (if answer is yes, describe briefly)
   • Proprietary interests: I (have/ do not have) proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces). (add description of interest)
   • Financial interests: I (have/ do not have) ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work. (add description of interest; relevant financial relationships between members should be disclosed)
   • Employment, consultancy, directorship or other positions: (describe any interests relevant to the MCTOC activity).
   • Government advice and other policy development: (describe any interests relevant to the MCTOC activity, including any provision of advice to government, organisations or institutions involved in policy development)
   • Paid research activities, fellowships or grants: (describe any paid research activities, fellowships or grants relevant to the MCTOC activity)
   • Other interests:
5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee is (describe funding arrangements and source )
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I (have/have not) declined to disclose information falling within paragraph 10 of those Guidelines (if have declined, add the following at the end of this statement “and I undertake to ensure that I am completely excluded from discussion and decisions on topics related to the information that I have declined to disclose”). 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Hideo Mori
Date: April 13th , 2021